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           The skin is a highly active immunological organ 
that contains a multitude of specialized immune 
cells. Among them, epidermal Langerhans cells 
(LCs), dermal DCs, and macrophages play a 
key role in the initiation and regulation of im-
mune responses (  1  ). A unifying feature is their 
hematopoietic origin and expression of HLA-
DR. LCs and dermal DCs are professional 
APCs that express high levels of HLA-DR and 
CD1c (  2  ). In humans, LCs can be identifi  ed 
by the expression of Langerin (CD207) (  3  –  6  ), 
whereas the heterogeneous dermal DCs can be 
classifi  ed according to the expression of CD1a 
and various monocyte/macrophage markers 
(  4, 7, 8  ). Skin macrophages, in contrast, express 
low levels of HLA-DR molecules and lack 
CD1c (  6, 9  ). To date, various blood-borne and 
skin-resident precursors for LCs, dermal DCs, 
and macrophages have been described (  10  –  15  ). 
Despite a considerable number of in vitro stud-
ies, the relationship among these cells, as well as 
the factors that control their immigration, dif-
ferentiation, and proliferation under homeo-
static and infl  ammatory conditions, remains 
unclear in humans. During skin development, 
LC, dermal DC, and macrophage precursors 
are believed to colonize the embryonic skin, 
showing a primitive surface marker pattern that 
subsequently develops into the profi  le of resi-
dent cells found in adult skin (  16, 17  ). Thus, 
the study of the ontogeny of APCs during 
human intrauterine development provides a 
unique opportunity to evaluate these processes 
as well as their relationship in this human 
in vivo model. 
  During human embryogenesis, leukocytes 
have been fi  rst described in the yolk sac by 
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  Adequate numbers and functional maturity are needed for leukocytes to exhibit a protec-
tive role in host defense. During intrauterine life, the skin immune system has to acquire 
these prerequisites to protect the newborn from infection in the hostile external environ-
ment after birth. We investigated the quantitative, phenotypic, and functional development 
of skin leukocytes and analyzed the factors controlling their proliferation and traffi  cking 
during skin development. We show that CD45  +   leukocytes are scattered in embryonic 
human skin and that their numbers continuously increase as the developing skin generates 
an environment that promotes proliferation of skin resident leukocytes as well as the infl  ux 
of leukocytes from the circulation. We also found that CD45  +  HLA-DR  high  CD1c  +   dendritic 
cells (DCs) are already present in the epidermis and dermis at 9 wk estimated gestational 
age (EGA) and that transforming growth factor     1 production precedes Langerin and CD1a 
expression on CD45  +  CD1c  +   Langerhans cell (LC) precursors. Functionally, embryonic anti-
gen-presenting cells (APCs) are able to phagocytose antigen, to up-regulate costimulatory 
molecules upon culture, and to effi  ciently stimulate T cells in a mixed lymphocyte reaction. 
Collectively, our data provide insight into skin DC biology and the mechanisms through 
which skin DCs presumably populate the skin during development. 
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pernatants of embryonic compared with adult skin (  Fig. 2 A  ).   
No obvious diff  erences in M-CSF concentrations among all 
investigated age groups were observed (  Fig. 2 A  ), and IL-3 
was not detectable (not depicted). In addition to the local 
proliferation of skin-resident leukocytes, their numerical in-
crease may also be caused by the attraction of leukocytes from 
around 5 wk estimated gestational age (EGA) on the basis of 
staining reactivity for various DC and macrophage markers, 
including HLA-DR (  18  ). The few studies investigating the 
development of leukocytes in human skin focused primarily 
on LCs (  16, 19, 20  ); therefore, our knowledge about the 
ontogeny of dermal DCs, macrophages and other skin leuko-
cytes is scarce (  17, 21  ). HLA-DR  +   cells have been described 
in skin at 7 wk EGA. Apart from their rare occurrence, they 
also diff  er morphologically and phenotypically from leuko-
cytes in adult skin. At 7 wk EGA, some epidermal cells already 
express HLA-DR, but not CD1a or Lag antigen, a component 
of Birbeck granules, which appear at     12 wk EGA (  16, 19  ). 
To better understand the development of professional skin 
APCs and to gain information about the organization of the 
skin immune system in utero, we investigated the quantita-
tive, phenotypic, and functional development of leukocytes 
and analyzed the factors that might control their proliferation 
and traffi   cking during human skin development. 
    RESULTS   
  Embryonic and fetal skin, but not adult skin, contains high 
numbers of proliferating leukocytes 
  During intrauterine life, the skin immune system has to ac-
quire the prerequisites to protect the newborn from infection 
in the hostile environment after birth, which includes the 
formation of a leukocyte network. To explore the kinetics of 
leukocyte numbers in developing and adult human skin, we 
enzymatically digested whole skin and analyzed the percent-
age of CD45  +   leukocytes using fl  ow cytometry. We found 
that relative leukocyte numbers among all skin cells in devel-
oping skin increase from 1.13% in embryonic skin (9  –  14 wk 
EGA) to 2.97% in fetal skin (18  –  24 wk EGA), which is sig-
nifi  cantly lower than in adult skin (11.59%;   Fig. 1 A  ).   To ex-
clude skin digestion  ’  s infl  uence on the quantity of released 
leukocytes, we analyzed in parallel the development of the 
absolute leukocyte numbers by counting CD45  +   cells in skin 
sections. This confi  rmed that leukocyte numbers are signifi  -
cantly lower in embryonic and fetal skin than in adult skin 
(  Fig. 1 B  ). To test whether the increase in leukocyte numbers 
in developing skin is caused by proliferating leukocytes, skin 
sections were counterstained with the nuclear proliferation 
marker Ki67. We found that 17.0% of CD45  +   cells in embry-
onic skin, but only 3.7% in fetal skin and 0.9% in adult skin, 
expresses Ki67 (  Fig. 1 C  ). Triple immunofl  uorescence stain-
ing of skin sections revealed that Ki67 is found in CD45  +  HLA-
DR  +   leukocytes in both the dermis and the epidermis (  Fig. 
1 D  , arrows; and not depicted) and in dermal CD45  +  HLA-
DR        leukocytes (not depicted) in all developmental stages as 
well as in adult skin. CD45       Ki67  +   cells represent, among 
others, proliferating keratinocytes, fi  broblasts and endothelial 
cells. We next asked whether the high rate of proliferating 
leukocytes in embryonic and fetal skin could be explained by 
higher concentrations of proliferation-inducing cytokines. 
Indeed, analysis of skin cell culture supernatants from embry-
onic, fetal, and adult single cells revealed that GM-CSF, SCF, 
and IL-6 concentrations are fi  ve- to sevenfold higher in su-
    Figure 1.         Proliferating CD45  +   cells contribute to the increase of 
leukocyte numbers in developing skin.   Dot graphs show the increase of 
relative (A) and absolute (B) numbers of CD45  +   leukocytes in developing 
skin analyzed by fl  ow cytometry and immunofl  uorescence, respectively. 
(C) The percentage of Ki67  + CD45 +   cells among total CD45  +   skin  cells 
during different stages of development was determined. 9-14 wk EGA: A, 
  n   = 18; B,   n   = 9; C,   n   = 7. 18  –  24 wk EGA: A and B,   n   = 9 each; C,   n   =  7. 
Adult:  A – C,   n   = 7 each. Bars represent the mean of investigated groups. 
(D) Immunofl  uorescence triple labeling identifi  ed proliferating CD45  + HLA-
DR  + Ki67 +   cells (arrows) in all investigated age groups. Alexa Fluor 488  –
  labeled Laminin5 mAb visualizes the dermo-epidermal junction. Shown is 
one representative experiment of three independent experiments per 
group with similar results. Bars, 50   μ  m.     JEM VOL. 206, January 19, 2009 
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cytokines, we determined the percentage of keratinocytes, 
leukocytes, and CD45        dermal cells in single cell suspensions 
of whole embryonic and adult skin. The morphology of skin, 
including the number of cell layers in the epidermis and the 
overall thickness, changes markedly during development, and 
the cellular composition of single cell suspensions refl  ects this 
development (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20081747/DC1). Using CDCP1 (CD318), 
a cell surface marker for keratinocytes and hematopoietic stem 
cells (  22, 23  ), we found that embryonic single cell suspensions 
contain 8.28% keratinocytes (i.e., CD318  +   but CD45        cells), 
1.13% CD45  +   leukocytes, and, consequently, 90.59% der-
mal CD45        cells. In contrast, single cell suspensions of adult 
skin contain more keratinocytes (60.53%) and leukocytes 
the circulation. As it is impossible to directly study the infl  ux 
of leukocytes into skin in humans, we measured surrogate 
markers for leukocyte immigration such as chemokine levels. 
We found that MCP-1 (CCL2) concentrations are 80-fold 
higher and RANTES (CCL5) levels are twofold higher in 
supernatants from embryonic skin than from adult skin (  Fig. 
2 B  ). In contrast to MCP-1, RANTES reaches adult-like 
levels already at 18  –  24 wk EGA. We observed no signifi  cant 
diff  erences in CCL20 and MDC (CCL22) concentrations 
among all age groups investigated (unpublished data). 
  To evaluate to what extent cells of the epidermal and 
the dermal compartment may contribute to the measured 
    Figure 2.         Cell culture supernatants of embryonic skin contain 
higher levels of proliferation-inducing growth factors and chemo-
kines than adult skin.   Single cell suspensions of embryonic (9  –  14 wk 
EGA), fetal (18  –  24 wk EGA), and adult skin were cultured for 48 h, and 
levels of proliferation-inducing growth factors (A) and chemokines (B) in 
supernatants were analyzed by ELISA and Luminex technology. Bars rep-
resent the mean of investigated groups. 9-14 wk EGA: GM-CSF,   n   =  12; 
SCF,   n   = 10; IL-6,   n   = 12; M-CSF,   n   = 10; MCP-1,   n   = 12; RANTES,   n   =  12. 
18  –  24 wk EGA: GM-CSF,   n   = 5; SCF,   n   = 7; IL-6,   n   = 5; M-CSF,   n   =  7; 
MCP-1,   n   = 5; RANTES,   n   = 5. Adult GM-CSF,   n   = 7; SCF,   n   = 5; IL-6,   n   =  6; 
M-CSF,   n   = 4; MCP-1,   n   = 7; RANTES,   n   =  7.   
    Figure 3.         HLA-DR  +   leukocytes are present in the skin already at 
9 wk EGA.   (A) Multiparameter fl  ow cytometry of freshly isolated single 
cells of embryonic, fetal, and adult skin was performed by incubation with 
mAb against the cell surface markers indicated. Dead cells were excluded 
by 7-AAD uptake. Quadrants in dot plots were set according to isotype-
matched control staining. Dot plots display 60,000 cells and are represen-
tative of 5  –  15 experiments (compare Fig. S2, available at http://www.jem
.org/cgi/content/full/jem.20081747/DC1). (B) Immunofl  uorescence double 
staining for the markers indicated was performed on cryostat sections of 
embryonic, fetal, and adult skin. One of at least three experiments per 
group is shown. Arrows denote CD45  + HLA-DR high   cells and arrowheads 
denote CD45  + HLA-DR low   cells.  Bars,  50   μ m.   172 ONTOGENY OF HUMAN HLA-DR  +   SKIN LEUKOCYTES   | Schuster et al. 
to CD45  +   leukocytes in embryonic skin, CD45       HLA-DR  +   
cells were fi  rst detected in fetal skin, although less frequently than 
in adult skin (  Fig. 3 A  ; Fig. S2 B). Immunofl  uorescence   locates 
CD45  +  HLA-DR  high   cells in the epidermis and the dermis, 
whereas CD45  +  HLA-DR  low   cells are found exclusively in the 
dermis (  Fig. 3 B  , arrowheads). Using collagen type IV to depict 
the basement membrane of vessels, we detected CD45       HLA-
DR  +   cells in fetal and adult skin lining the luminal side of the 
basement membranes of vessels, thereby confi  rming their endo-
thelial nature (Fig. S2 C). Keratinocytes show no expression of 
HLA-DR in all samples investigated. 
  Some HLA-DR  high   leukocytes coexpress CD1c 
in embryonic skin 
  Skin DCs can be distinguished from macrophages by the 
expression of CD1 antigens (  6, 9, 26  ). To address whether 
HLA-DR  +   leukocytes in embryonic skin are already com-
mitted to the DC lineage, we analyzed whether they coexpress 
(11.59%) and, thus, lower numbers of CD45        dermal cells 
(27.64%) than embryonic skin (Table S1, available at http://
www.jem.org/cgi/content/full/jem.20081747/DC1). 
  HLA-DR  +   leukocytes are present in embryonic skin 
  In healthy adult skin CD45  +   LCs, dermal DCs, macrophages, and 
a fraction of CD45        endothelial cells express HLA-DR (  24, 25  ). 
To explore the development of CD45  +  HLA-DR  +   leukocytes, 
we analyzed embryonic, fetal, and, for comparison, adult skin 
by fl  ow cytometry. We found that CD45  +  HLA-DR  +   cells are 
already present in embryonic skin, although in lower frequency 
than in fetal or in adult skin (  Fig. 3 A   and Fig. S2 A, available at 
http://www.jem.org/cgi/content/full/jem.20081747/DC1), 
thus confi  rming and extending fi  ndings of previous studies 
(  16, 19, 21  ).   In contrast to adult skin, where the majority of 
CD45  +  HLA-DR  +   leukocytes express high levels of this marker, 
developing skin shows a continuum of HLA-DR  low   to HLA-
DR  high   leukocytes. Although HLA-DR expression is restricted 
    Figure 4.         Not all HLA-DR  +   epidermal leukocytes express CD1c at 9 wk EGA.   (A) Flow cytometric analysis revealed the presence of CD45  + CD1c +  
cells in embryonic skin. Histograms display HLA-DR staining (black line) of CD45  + CD1c +   (R1) and CD45  + CD1c       (R2). Gray line, isotype control. Shown are 
representative dot plots of three to fi  ve experiments per group. (B) Immunofl  uorescence triple labeling identifi  ed HLA-DR  + CD1c       (arrows) and HLA-
DR  + CD1c +   (not depicted) leukocytes in embryonic epidermis. Arrowheads denote CD45  + HLA-DR + CD1c +   cells. Data are representative of at least three 
  experiments per group. Bars, 50   μ  m.     JEM VOL. 206, January 19, 2009 
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  Several studies demonstrated that LC development is de-
pendent on TGF-    1 (  14, 15, 28  –  30  ). We therefore asked 
whether the acquisition of the LC phenotype correlates with 
the incipient production of this cytokine in the epidermis. 
  Immunohistochemical analysis revealed that the TGF-    1 pre-
cursor protein LAP is already detectable at 8 wk EGA in the 
periderm, which is a protective development-specifi  c cell layer 
covering the basal layer (Fig. S4, available at http://www.jem
.org/cgi/content/full/jem.20081747/DC1). Within the next 
CD1c. Indeed, using fl  ow cytometry, we identifi  ed a small 
CD45  +  CD1c  +   population in embryonic skin that shows high 
expression of HLA-DR (  Fig. 4 A  , R1).   The CD45  +  CD1c        
population contains a small population expressing low levels 
of HLA-DR (  Fig. 4 A  , R2). Both populations are found in 
much higher frequencies in adult skin, where higher levels 
of HLA-DR expression are also found. Immunofl  uores-
cence revealed the presence of CD45  +  HLA-DR  +  CD1c  +   
cells in the dermis (  Fig. 4 B  , arrowheads) and the epider-
mis (not depicted; compare   Fig. 5 B  , left).   Not all epider-
mal CD45  +  HLA-DR  +   leukocytes in embryonic skin express 
CD1c, indicating that either immature or uncommitted epi-
dermal LC precursors acquire this antigen in the epidermis 
(  Fig. 4 B  , arrows). However, CD1c may also be expressed on 
B cells (  6, 27  ). To exclude the B cells contained by CD1c  +   
population, we analyzed developing skin for the presence of 
CD19  +   B cells by fl  ow cytometry. As we could not detect 
CD19  +   cells in embryonic and fetal skin (unpublished data), 
our data indicate that CD1c  +   cells in developing skin are ex-
clusively DCs. 
  CD45  +  CD1c  +   LC precursors acquire Langerin and CD1a 
in the epidermis 
  To test whether LC precursors acquire their surface marker 
profi  le in the skin, we analyzed the expression of the LC 
markers Langerin and CD1a during skin development. We 
found that Langerin is absent on CD45  +  CD1c  +   cells between 
9 and 10 wk EGA (  Fig. 5, A and B  , left). It exclusively ap-
pears on CD45  +  CD1c  +   cells in the epidermis after 11 wk 
EGA (  Fig. 5, A and B  , middle, arrows). We demonstrate that 
embryonic (  Fig. 5 B  , arrowheads) and fetal (not depicted) 
epidermis contain LCs in diff  erent developmental stages with 
regard to CD1c and Langerin expression. In addition, Lan-
gerin expression precedes CD1a acquisition. CD1a is not 
found on CD45  +  HLA-DR  +  Langerin        and CD45  +  HLA-
DR  +  Langerin  low   cells until 13 wk EGA (  Fig. 6 A  ).   Thereafter, 
Langerin  low  CD1a        and Langerin  high  CD1a  +   leukocytes can be 
identifi  ed.  Immunofl   uorescence reveals that these changes 
take place in the epidermis, given that both Langerin  +  CD1a  +   
and Langerin  +  CD1a        epidermal leukocytes can be detected 
(  Fig. 6 B  , middle, insets). CD1a  +  Langerin        dermal DCs are 
not present in developing skin before 18  –  24 wk EGA. At 
this stage of development, the staining pattern of Langerin and 
CD1a resembles very much the pattern observed in adult skin, 
even though the frequency is lower. Surprisingly, dendritic 
Langerin       CD1a        cells are still found in the epidermis at the 
end of the second trimester (  Fig. 6 B  , arrowheads). To ex-
clude death and replacement of these LC precursors, we ana-
lyzed developing skin for the presence of apoptotic CD45  +   
leukocytes. As we did not detect terminal deoxynucleotidyl 
transferase-mediated dUTP nick end labeling (TUNEL)  +   
leukocytes in embryonic and fetal skin (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20081747/DC1), 
our data strongly indicate that LC precursors acquire CD1c, 
Langerin, and CD1a in the epidermis during intrauterine de-
velopment in a stepwise manner. 
    Figure 5.         Epidermal leukocytes sequentially acquire CD1c and 
Langerin.   CD1c and Langerin expression in developing human skin 
was assessed by fl  ow cytometry (A) and in situ by immunofl  uores-
cence staining (B). (A) Dot plots show the development of CD45  +  
cells with regard to the expression of CD1c and Langerin (2,500 
CD45  +   cells displayed) and are representative of three to fi  ve experi-
ments per group. (B) Immunofl  uorescence triple labeling identifi  es 
CD45  + CD1c + Langerin +   cells (middle, arrows) at 11 wk EGA. Arrowheads 
denote a CD45  + CD1c     Langerin       LC precursor. Data are representative 
of at least three experiments per group. Bars, 50   μ  m.     174 ONTOGENY OF HUMAN HLA-DR  +   SKIN LEUKOCYTES   | Schuster et al. 
Already at the end of the second trimester, the epidermal 
TGF-    1 staining pattern resembles the one observed in adult 
skin, apart from a general weaker staining intensity. As de-
scribed in adult skin (  31  ), throughout development TGF-    1 
is primarily localized in the epidermis. 
  Embryonic HLA-DR  high   leukocytes are functional 
  It has been speculated that embryonic and fetal leukocytes 
exhibit intrinsic functional defi  ciencies, a concept which may 
explain some defi  cits of the neonatal immune system (  32  –  35  ). 
weeks of development, production of LAP shifts to the basal 
epidermal layer but can still be found in the other layers, 
which is a staining pattern comparable to that of adult skin. 
The active form TGF-    1 is fi  rst detectable in the primitive 
epidermis at 9 wk EGA (  Fig. 7  ).   After the beginning of strati-
fi  cation, strong intracellular TGF-    1 expression is found in 
the intermediate cell layers between the periderm, which 
shows faint TGF-    1 staining reactivity until its disintegra-
tion at the end of the second trimester, and the basal layer, 
which never shows TGF-    1 production during development. 
    Figure 6.         Epidermal leukocytes sequentially acquire Langerin and CD1a.   CD1a and Langerin expression in developing skin was assessed by fl  ow 
cytometry (A) and immunofl  uorescence (B). (A) Dot plots are representative of three to fi  ve experiments per group and show the development of 
CD45  + HLA-DR +   cells with regard to the expression of CD1a and Langerin (1,200  –  2,400 cells displayed). (B) The fi  rst Langerin  + CD1a       LC precursors are 
identifi  ed by immunofl  uorescence at 11 wk EGA (second column, arrows). CD1a expression is found on some (middle, left insets) but not all (middle, right 
insets) CD45  + Langerin +   cells at 13 wk EGA. Arrowheads denote a CD45  + Langerin     CD1a       LC precursor. Data are representative of at least three experi-
ments per group. Bars, 50   μ  m.     JEM VOL. 206, January 19, 2009 
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levels in developing skin are half of what is found in adult 
skin, IL-10 concentrations in embryonic (50-fold) and fetal 
(18-fold) skin cultures far exceed those secreted by skin cells 
from adults (  Fig. 8 D  ), suggesting that developing skin repre-
sents an immunosuppressive environment. 
    DISCUSSION   
  We showed in this study that human embryonic skin harbors 
phenotypically diverse and functionally potent HLA-DR  +   
leukocytes. We also demonstrated that human developing 
skin generates an environment that promotes proliferation of 
skin-resident leukocytes and probably immigration of blood 
borne precursors, thereby actively contributing to the forma-
tion of the skin immune system. Given that only small 
amounts of embryonic and fetal tissue were available because 
of ethical limitations and that embryonic skin contains only 
few leukocytes, we primarily investigated the development 
of HLA-DR  +   leukocytes. 
  The increase in leukocyte numbers in developing skin 
is dependent on their local proliferation and immigration 
  Adult skin contains a dense network of DCs and macrophages 
that control a spectrum of innate and adaptive immune re-
sponses (  37, 38  ). In human embryonic skin, this network has 
not yet formed, implicating an insuffi   cient host defense in 
case the epidermal barrier is breached. During skin devel-
opment, this network continuously develops, probably as a 
consequence of proliferating resident leukocytes and of leu-
kocyte immigration. The fi  rst assumption is based on our 
observations of a high rate of leukocytes expressing the pro-
liferation marker Ki67 in embryonic and fetal skin. In support 
of this observation, we found small clusters of two to four 
leukocytes in skin sections, which is also indicative of local 
proliferation. Moreover, our fi  ndings that supernatants of 
embryonic and, to a lesser extent, fetal skin cell cultures con-
tain higher levels of growth factors, such as GM-CSF, SCF, 
and IL-6, compared with adults are suggestive of the pres-
ence of a cytokine milieu in developing skin that stimulates 
To address whether CD45  +  HLA-DR  +   leukocytes from embry-
onic skin are functionally active, we analyzed their capacity 
to phagocytose bacteria, up-regulate costimulatory molecules 
during culture, and induce a primary T cell response in vitro. 
We found that a considerable fraction of embryonic skin leu-
kocytes internalize opsonised FITC   Escherichia coli   at 37  °  C 
but not at 4  °  C (  Fig. 8 A  , left).   Additional phenotypic charac-
terization revealed that uptake of bacteria is restricted to 
HLA-DR  low   and HLA-DR  high   leukocytes. In contrast, in 
single cell suspensions of adult skin, only HLA-DR  high   leuko-
cytes take up FITC-labeled   E. coli  . Although 46.97% (SD 
14.3%;   n   = 3) of HLA-DR  +   leukocytes take up   E. coli   in em-
bryonic skin, only 10.74% (SD 5.0%;   n   = 3) of HLA-DR  +   leu-
kocytes take up the labeled bacteria in adult skin (  Fig. 8  , right). 
The reason for this diff  erence remains to be investigated. 
  It is well established that potent T cell stimulation re-
quires high levels of costimulatory molecules on DCs (  36  ). 
To test whether embryonic HLA-DR  –  expressing skin leu-
kocytes up-regulate molecules relevant for T cell activa-
tion, single cell suspensions were cultured. Freshly isolated 
HLA-DR  +   leukocytes express neither CD80 nor CD83 
but low levels of CD86 (unpublished data). However, after 
48 h of culture, HLA-DR  high   but not HLA-DR  low   leukocytes 
up-regulate CD80, CD83, and CD86, thus representing a 
phenotype consistent with the ability of priming immune 
responses (  Fig. 8 B  ). To confi  rm this, we enriched CD1c  +   
cells (purity range 40  –  70%) using magnetic bead separation 
and compared their allostimulatory capacity with those of 
the CD1c        fraction, containing   <  0.1% CD1c  +   cells. Re-
peated experiments showed that embryonic CD1c  +   cells, but 
not CD1c        cells, elicit vigorous proliferation of allogeneic 
T cells (  Fig. 8 C  ). 
  To address whether the phenotype and functionality of 
leukocytes in developing skin may be infl  uenced by a specifi  c 
development-related milieu, we comparatively assessed the 
concentrations of the proinfl  ammatory cytokine IL-1     and 
the immunosuppressive cytokine IL-10 in supernatants of 
embryonic, fetal, and adult skin cell cultures. Although IL-1     
    Figure 7.         Epidermal TGF-    1 production precedes the acquisition of the LC phenotype.   Double immunohistochemical staining was performed on 
cryostat sections of embryonic, fetal, and adult human skin. TGF-    1 was visualized with AEC (red). The dermo-epidermal junction was identifi  ed both in 
the TGF-    1 staining and in the controls with mAb directed against collagen type IV until 14 wk EGA and Laminin5 in the remaining age groups and visu-
alized with diamino-benzidine-tetrahydrochloride (DAB; brown line). Data are representative of at least three experiments per group.  Bars,  50   μ m.   176 ONTOGENY OF HUMAN HLA-DR  +   SKIN LEUKOCYTES   | Schuster et al. 
    Figure 8.         Embryonic DC precursors ingest   E. coli  , up-regulate costimulatory molecules during culture, and stimulate allogeneic T cells.  
(A) Phagocytic capacity of leukocytes from embryonic (9  –  14 wk EGA) and adult skin was assessed by the uptake of FITC-labeled   E. coli   (10 7   bacteria/2   ×  
10  6   cells). Flow cytometric analysis revealed exclusive uptake of bacteria in CD45  + HLA-DR +   cells (R1). Data are representative of three experiments in em-
bryonic skin and of three experiments in adult skin. (B) Single cells from embryonic skin were cultured for 48 h and expression of CD80, CD86 (donor 1), 
and CD83 (donor 2) on HLA-DR  +   cells was analyzed (gated on CD45  +   cells). Shown are two representative experiments out of three to fi  ve. (C) Allogeneic 
T cells (5   ×   10  4  /well) were cocultured with graded numbers of CD1c  +   and  CD1c       stimulator cells from embryonic skin. T cell proliferation was determined 
after 5 d by measuring the incorporation of [  3  H]thymidine. Data are displayed as the mean   ±   SD of triplicate cultures, and one representative of three JEM VOL. 206, January 19, 2009 
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results, which may be partially explained by the use of diff  er-
ent cell isolation techniques. Some studies describe dimin-
ished levels of HLA-DR on cord blood monocytes, which 
should explain the defi  cient T cell priming of these cells (  51  ). 
In contrast, other investigators did not fi  nd defi  cient function 
of cord blood DCs (  52, 53  ). In this paper, we show that 
APCs already in embryonic skin effi   ciently take up antigen, 
up-regulate costimulatory molecules, and stimulate alloge-
neic T cells in vitro, suggesting that they are not intrinsically 
inhibited and that the skin already in utero possesses the ma-
chinery to mount vigorous immune responses. Indeed, vari-
ous studies have already shown that human fetuses are capable 
of generating vigorous immune responses after transplacental 
spread of infectious agents, including parasites and viruses 
(  54  –  57  ). It has been therefore hypothesized that the immune 
system of human fetuses is actively suppressed rather than 
functionally defi  cient (  58  ). This suppression may be related 
to high numbers of regulatory T cells in fetal circulation, 
lymph nodes (  58  ), and decidual tissue (  59  ) as well as to an 
immunosuppressive environment generated by the placenta 
(  60  ). Furthermore, it is known that IL-10 is present in amni-
otic fl  uid, and its antiinfl  ammatory function is postulated to 
play an important role in the prevention of an infl  ammatory 
response to the fetus and fetal   “  foreign  ”   antigens (  61, 62  ). 
Similar to our previous observations in mice (  63  ), our results 
show that in developing human skin high levels of the im-
munosuppressive cytokine IL-10 together with low levels 
of the proinfl   ammatory cytokine IL-1     could inhibit the 
activation and mobilization of skin DCs and macrophages, 
thus contributing to the acquisition or maintenance of im-
mune tolerance. 
  LC and dermal DCs acquire their marker profi  le during 
skin development 
  The study of the ontogeny of skin APCs also provides a 
unique opportunity to evaluate the development and, thus, 
the phenotype of their precursor cells. In addition, despite 
considerable research, the relationship among LCs, dermal DCs, 
and skin macrophages still remains unclear, not least because 
of the high plasticity of precursors to diff  erentiate into each of 
these cells in diff  erent microenvironments (  7, 12, 15  ). In this 
study, we show that at 9 wk EGA, skin macrophages and 
DCs can already be phenotypically separated by the distinct 
expression of the DC marker CD1c on some HLA-DR  high   
cells. HLA-DR  high   leukocytes are capable of phagocytosing 
bacteria, up-regulating costimulatory molecules, and stimu-
lating proliferation of allogeneic T cells in vitro, thus con-
fi  rming their DC nature. In contrast, HLA-DR  low   skin 
macrophages neither express CD1c nor up-regulate costimu-
latory molecules during culture. Collectively, these data show 
that at 9 wk EGA, skin macrophages and DCs can already be 
proliferation of skin-resident leukocytes. These growth fac-
tors, either alone or in combination, have been described to 
stimulate the proliferation of cells such as hematopoietic stem 
and progenitor cells, DCs, and other cell types (  39  –  43  ). M-CSF, 
which is present in similar amounts in supernatants of embry-
onic, fetal, and adult skin cells, may also stimulate prolifera-
tion of hematopoietic progenitor cells but, in concert with 
GM-CSF, might also play a role in the maturation of mac-
rophages and DCs (  43  ). Apart from the local proliferation of 
immune cells, the leukocyte network in developing skin is 
probably reinforced by the immigration of leukocyte precur-
sors from the circulation. Indeed, we occasionally observed 
leukocytes sticking to the luminal surface of CD34  +   vessels in 
developing skin (unpublished data), corroborating leukocyte 
recruitment into skin. 
  The migration of leukocytes into skin largely depends on 
chemokines (  44, 45  ), a concept which can also be expected 
in developing skin. Various leukocyte-attracting chemokines 
are produced in high levels during infl  ammation, including 
MCP-1 (CCL2), RANTES (CCL5), MIP-3     (CCL20), and 
MDC (CCL22) (  45  –  50  ). We found higher concentrations of 
MCP-1 and RANTES, but not of MIP-3     and MDC, in 
supernatants of developing skin than in adult skin. In addi-
tion, RANTES levels reach adult-like levels by 18  –  24 wk 
EGA, whereas MCP-1 levels remain high. Collectively, these 
fi  ndings point to a tightly regulated program of leukocyte at-
traction into skin during development that diff  ers from that 
found during skin infl  ammation. Collectively, these results 
suggest that blood-borne precursors are recruited to the skin 
owing to this unique chemokine milieu, yet defi  nitive evi-
dence cannot be provided from our studies. However, it can-
not be ruled out that chemokines that have so far not been 
implicated in the recruitment of leukocytes in skin may play 
a role during skin development. Furthermore, our data that 
the cellular composition of embryonic and adult single cell 
suspensions diff  ers with regard to numbers of keratinocytes, 
leukocytes, and dermal CD45        cells complicates the elucida-
tion of which cells these cytokines are produced by. 
  Leukocytes from embryonic skin are functionally 
not intrinsically inhibited 
  Adequate numbers and functional maturity are needed for 
leukocytes to exhibit a protective role in host defense. For 
the fi  rst time, this study sheds light on the functional state of 
APCs in human embryonic and fetal skin because we were 
able to isolate the rare DC precursors from embryonic skin in 
numbers suffi   cient to perform meaningful functional experi-
ments. Previous studies investigating the effi   ciency of APCs 
of human fetuses have relied on the use of APCs in umbilical 
cord blood, given the diffi   culties in obtaining human embry-
onic and fetal tissue (  34  ). These studies yielded controversial 
independent experiments is shown. (D) Single cell suspensions of embryonic, fetal, and adult skin were cultured for 48 h, and IL-1     and IL-10 levels in 
supernatants were analyzed by Luminex technology. Bars represent the mean of investigated groups. 9-14 wk EGA: IL-1     and IL-10,   n   = 12 each. 18  –  24 wk 
EGA: IL-1     and IL-10,   n   = 5 each. Adult: IL-1     and IL-10,   n   =  7  each.   
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onset of stratifi  cation correlates with the appearance of Lan-
gerin and CD1a, corroborating the possible role of TGF-    1 
in humans in the acquisition of the LC phenotype in vivo. In 
addition, the increasing staining intensity of Langerin and 
CD1a in fetal skin may refl  ect the consistently increasing total 
amount of TGF-    1 in the developing epidermis. However, 
TGF-    1 is also known to exert a wide range of eff  ects on 
keratinocytes, including potent growth inhibition. The ex-
clusive suprabasal staining pattern found in healthy adult epi-
dermis may represent a compartmental regulation to exclude 
the proliferating basal layer from the inhibitory growth eff  ect 
of TGF-    1 (  31  ). This hypothesis is supported by our fi  nding 
that, after the onset of epidermal stratifi  cation around 9 wk 
EGA, TGF-    1 is found exclusively suprabasally. The pro-
duction of TGF-    1 in suprabasal layers, and temporarily in 
the periderm, implies an important regulatory role of TGF-
    1 in the diff  erentiation and proliferation of keratinocytes 
also in developing epidermis, apart from its possible role in 
the generation of the LC phenotype. The secreted inactive 
form of TGF-    1, LAP, is found in the primitive epidermis 
earlier than the active form, suggesting that the release of ac-
tive TGF-    1 is regulated by the incipient LAP activation that 
develops around 9 wk EGA. The mechanism by which this 
is regulated has to be determined in further studies. 
  It has recently been shown that CD1a  +  Langerin        dermal 
DCs represent a subset of dermal DCs distinct from LCs that 
is capable of carrying antigen to lymph nodes and stimulating 
naive T cells (  8  ). We show that CD1a  +  Langerin  -   dermal DCs 
develop at 18  –  24 wk EGA, thereby confi  rming that these 
cells are distinct from CD1a  +  Langerin  +   epidermal LCs. To 
date, the origin of CD1a  +  Langerin        dermal DCs is specula-
tive. It is possible that skin-resident dermal DC precursors, 
such as dermal CD1c  +   cells which are already present in the 
skin at 9 wk EGA, acquire CD1a as a result of an intrinsic 
program or changing environmental factors. 
  HLA-DR expression on endothelial cells is not found before 
18  –  24 wk EGA 
  It is well established that a fraction of endothelial cells in 
healthy adult human skin express HLA-DR (  24, 25  ). HLA-
DR  +   endothelial cells are believed to play an important role in 
dampening T cell responses and in the maintenance of toler-
ance (  24  ). Alternatively, it has been speculated that these cells 
are involved in the activation of skin-homing T cells (  65  ). 
We show that HLA-DR expression on endothelial cells is 
not acquired before 18  –  24 wk EGA. IFN-     has been shown 
to induce HLA-DR expression in a variety of cells, including 
endothelial cells and keratinocytes (  66  ). Whether this proin-
fl  ammatory cytokine controls the acquisition of HLA-DR 
on endothelial cells remains to be investigated. Even though 
the function of HLA-DR  –  expressing endothelial cells dur-
ing midgestation is yet unknown, one may speculate that 
they have the potential to present peptide antigen and subse-
quently infl  uence the cutaneous immune environment. 
  In summary, we have shown that the study of the devel-
opment of the human skin immune system yields valuable 
identifi  ed and distinguished. Intriguingly, some HLA-DR  +   
epidermal leukocytes do not express CD1c at 9 wk EGA and, 
hence, acquire this antigen in the epidermis. It is therefore 
conceivable that CD45  +  HLA-DR  +   leukocytes represent 
common precursors for skin macrophages, dermal DCs, and 
LCs that develop into each subset owing to local microenvi-
ronmental cues. Alternatively, it might also be possible that 
CD45  +  HLA-DR  +   precursors committed to diff  erentiate into 
skin macrophages, LCs, and dermal DCs migrate into their 
residential compartment where they eventually acquire their 
mature phenotype. Further studies investigating the expres-
sion of CD11b, CD11c, and CD14 on these CD45  +  HLA-
DR  +   cells, as well as their departmental localization, should 
help to clarify the relationship of skin DCs and macrophages 
in humans. 
  In contrast to the heterogeneity of dermal immune cells, 
the sole presence of LCs in the epidermis facilitates the in-
vestigation of their development. We found that LC pre-
cursors sequentially acquire their phenotypic repertoire in 
the epidermis. They colonize the epidermis as CD45  +  HLA-
DR  +   leukocytes and then acquire CD1c, Langerin, and CD1a 
in a stepwise manner. Flow cytometric analyses suggest that the 
phenotype of LC precursors changes from Langerin       CD1a        
to Langerin  high  CD1a  high   via Langerin  high  CD1a        and Lan-
gerin  high  CD1a  +  . Because we could not detect apoptotic leu-
kocytes in embryonic and fetal skin, we conclude that 
epidermal LC precursors are not replaced by immigrating 
cells but acquire their phenotype in the epidermis. These 
fi  ndings contrast with an earlier study, showing that CD1a 
expression precedes Lag expression (  19  ). As it has been 
shown that the anti-Lag mAb recognizes an intracellular 
epitope of Langerin (  3  ), it is conceivable that the Langerin 
antibody recognizes a more accessible form of this antigen 
and, thus, allows an earlier identifi   cation of these cells. 
However, data from a recent study supports our view that 
Langerin expression on LC precursors precedes CD1a ac-
quisition. In this study, a migratory CD1a       CD14  +  CD207  +   
population is described that acquires CD1a and E-cadherin 
while down-regulating CD14 during short term culture 
with TGF-    1 (  12  ). It remains to be investigated whether 
embryonic CD45  +  HLA-DR  +   epidermal leukocytes express 
CD14. However, alternatives to the serial acquisition of 
markers on LCs in developing skin are conceivable. As the 
changes of the marker profi  le on LCs take place during the 
transition of hematopoiesis from fetal liver to the bone mar-
row (  64  ), it is possible that bone marrow  –  derived DCs that 
colonize developing skin display already a more mature sur-
face marker profi  le. Also, it cannot be excluded that LCs 
loose and regain certain surface markers during develop-
ment. Yet, given the ethical limitations when using human 
prenatal tissue, it is to date not possible to exclude any of 
these alternatives. 
  TGF-    1 has been shown to be a prerequisite for the for-
mation of the LC phenotype in vitro and in vivo (  15, 28, 30  ). 
In concordance with these studies, we demonstrate that 
the production of TGF-    1 in developing epidermis after the JEM VOL. 206, January 19, 2009 
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  Immunofl  uorescence.     Fixed sections were stained with the following un-
conjugated primary antibodies: anti-CD1a (WM35; Sanquin,), anti-CD1c 
(L161; AbD Serotec), anti-Langerin (DCGM4; Beckman Coulter), anti  –
  collagen type IV (24.12.8; Millipore), and anti-Ki67 (Leica) overnight at 
4  °  C. Primary antibodies were detected with the corresponding species-spe-
cifi  c donkey anti  –  mouse NorthernLight637 (R  &  D Systems) or goat anti  –
  rabbit Alexa Fluor 647 (Invitrogen) antibodies. Subsequently, sections were 
blocked with 10% mouse serum and 2% mouse IgG (BD) for 1 h at room 
temperature and stained with the following conjugated antibodies overnight 
at 4  °  C: Alexa Fluor 488 anti-Langerin (DCGM4; Dendritics), FITC anti  –
  HLA-DR (L243; BD), and Alexa Fluor 546 anti-CD45 (MEM28; provided 
by A. Muhammad, Medical University of Vienna, Vienna, Austria). Alexa 
Fluor 488 anti-Laminin5 (D4B5; Millipore) was used to visualize the dermo-
epidermal junction. Slides were mounted using Vectashield (Vector Labora-
tories) and images were recorded using a confocal laser scanning microscope 
(LSM 410; Carl Zeiss, Inc.) equipped with three lasers emitting lights at 488, 
543, and 633 nm. 
  Identifi  cation of apoptotic cells.     To detect DNA breaks in leukocytes in 
situ, cryostat sections were fi  xed with 4% paraformaldehyde for 20 min at 
room temperature and then washed three times in PBS. Sections were sub-
sequently subjected to TUNEL technique according to the manufacturer  ’  s 
instructions (Roche). After rinsing in PBS, sections were counterstained 
with Alexa Fluor 546 anti-CD45. As a positive control, sections were fi  rst 
incubated with 1,500 U/ml DNase I for 45 min at room temperature to 
  induce DNA breaks in the nucleus and were then subjected to CD45/
TUNEL staining. Images from four individuals from embryonic and three 
individuals from fetal skin were recorded using a confocal laser scanning 
microscope. 
  Quantifi  cation of cells in skin sections.     Ki67  +   and CD45  +   cells were 
enumerated by two independent investigators in at least 20 randomly 
selected microscopic fi  elds per sample (four to eight sections from seven 
to nine individuals were tested as specifi  ed in the fi  gures;   ×  20 objective 
lens; Nikon). 
  Phagocytosis assay.     The phagocytic capacity of leukocytes from embry-
onic skin (9  –  12 wk EGA) was assessed using a modifi  ed protocol for the 
Phagotest (ORPEGEN Pharma). In brief, 2   ×   10  6   skin cells were incubated 
for 90 min at 4 and 37  °  C with 10  7   inactivated opsonized FITC-conjugated 
  E. coli   cells in RPMI 1640 medium containing 10% FCS. To quench the 
fl  uorescence signal from attached but not internalized   E. coli  , cells were in-
cubated with the provided quenching solution. Cells were then washed with 
PBS and stained with the respective antibodies and isotype controls before 
fl  ow cytometric analysis. 
  DC isolation from embryonic skin.     CD1c  +   skin cells (11  –  14 wk EGA) 
were positively selected using PE anti-CD1c (AD5-8E7; Miltenyi Biotec), 
followed by anti-PE magnetic beads (Miltenyi Biotec). The purity of iso-
lated CD1c  +   cells was 40  –  70%, as determined by fl  ow cytometric analysis. 
CD1c  +   and CD1c        (containing   <  0.1% CD1c  +   cells) cells were then cultured 
for 24 h in medium containing 10% FCS and used for functional analysis. 
  Mixed leukocyte reaction.     Allogeneic CD3  +   responder T cells were puri-
fi  ed from PBMCs (  >  95% purity) by negative selection using a CD3 T cell 
isolation kit (Miltenyi Biotec). Graded numbers of stimulator cells (CD1c  +   
and CD1c       ) were cocultured with allogeneic CD3  +   T cells (5   ×   10  4  /well) 
in 96-well round-bottom microtiter plates (Costar; Corning) for 5 d. For the 
fi  nal 16 h of culture, cells were pulsed with [  3  H]thymidine (37 kBq/well; 
Hartmann Analytic), and the amount of incorporation of the radioisotope was 
determined with a 1450 Microbeta liquid scintillation counter (PerkinElmer). 
CD1c  +  , CD1c       , and purifi  ed T cells alone did not proliferate when cultured 
with medium (  <  600 cpm). Data are expressed as the mean cpm   ±   SD of 
triplicate cultures. 
information about the origin and relationship of leukocytes. 
Moreover, this study adds further data to the growing body 
of evidence that the human embryo and fetus possess the 
principal machinery to mount vigorous immune responses 
once the immunosuppressive environment is overcome. 
  MATERIALS AND METHODS 
  Skin samples.     After legal termination of pregnancy, 40 specimens of 
human embryonic and fetal trunk skin ranging from 8  –  24 wk EGA were 
studied. The age was estimated by crown-rump length and maternal history. 
The study was approved by the local ethics committee (Medical University 
of Vienna), and informed written consent was obtained from the parents. 
The ethics committee permitted the removal of 1.4 cm  2  /individual. Healthy 
adult skin was obtained after abdominal and breast surgery in accordance 
with the regulations of the Medical University of Vienna. 
  Preparation of skin cell suspensions.     After removal of subcutaneous tis-
sue, embryonic, fetal, and adult skin was incubated on 1.2 U/ml Dispase II 
(Roche) in PBS overnight at 4  °  C. It was not possible to effi   ciently separate 
dermis and epidermis in embryonic and fetal skin. Thus, unseparated skin, 
regardless of age, was vigorously agitated in a shaking bath in 0.53 U/ml 
Liberase3 (Roche) in PBS for 60  –  90 min. The resulting single cell suspen-
sions were analyzed by fl  ow cytometry, cultured for 48 h, or used for func-
tional studies. Cells were washed and cultured in normal cell medium (10  6   
cells/ml), composed of RPMI 1640 cell medium (Invitrogen) supplemented 
with 10% heat-inactivated FCS (PromoCell), 25 mM Hepes, 10   μ  g/ml 
gentamycin, 2 mM   l-  glutamine, 0.1 mM of nonessential amino acids, 1 mM 
sodium pyruvate, 50   μ  M 2-mercapto-ethanol, and 0.002% of antibiotic 
  antimycotic solution (all Invitrogen). 
  Flow cytometry.     Single cell suspensions were stained with the following 
mAbs: PE anti-Langerin (DCGM4), PE-Cy7 anti-CD45 (J.33; both 
Beckman Coulter), FITC anti-CD1a (HI-149), FITC anti-CD80 (L307.4), 
FITC anti-CD83 (HB15e), FITC anti-CD86 (2331), PE anti-CD318 
(CUB1), allophycocyanin and PE-anti-HLA-DR (L243; all BD), PE-anti-
CD19 (SJ25-C1; Invitrogen), and FITC anti-CD1c (M241; Ancell). Appro-
priate isotype controls were included. Dead cells were excluded with 7-AAD 
(EMD). Five-color fl  ow cytometry analyses were performed on an LSR-II 
(BD) and data were analyzed using FlowJo software (Tree Star, Inc.). 
  Immunohistochemistry.     Embryonic, fetal, and adult skin specimens were 
embedded in optimum cutting tissue compound (Tissue-Tek; Sakura), snap 
frozen in liquid nitrogen, and stored at     80  °  C until further processing. 
6-  μ  m sections were cut, air dried, fi  xed in ice-cold acetone for 10 min, and 
washed in PBS. Sections were then incubated with anti-collagen type IV 
(24.12.8; Millipore) or anti-Laminin5 (D4B5; Millipore) overnight at 4  °  C, 
followed by blocking of endogenous peroxidase activity by incubating 
sections for 10 min in methanol containing 0.03% hydrogen peroxide. Sub-
sequently, sections were incubated for 2 h at room temperature with biotin-
conjugated goat anti  –  mouse IgG using the Elite mouse IgG Vectastain kit 
(Vector Laboratories). Biotinylated antibodies were detected with HRP 
streptavidin and staining was visualized with DAB (Vector Laboratories) 
supplemented with Ni  2+  . Remaining peroxidase activity was blocked 
for 10 min with 0.03% hydrogen peroxide/methanol. Tissue sections were 
then incubated with anti-LAP (27232; R  &  D Systems) and anti  –  TGF-    1 
  serum (Santa Cruz Biotechnology, Inc.) overnight at 4  °  C, followed by 
biotin-conjugated goat anti  –  mouse or goat anti  –  rabbit IgG for 2 h at room 
temperature using the Elite mouse IgG and Elite rabbit IgG Vectastain kits. 
Biotinylated antibodies were detected with HRP streptavidin and staining 
was visualized with amino-ethyl-carbazole (AEC; Dako). Finally, sections 
were mounted with Aquatex (Merck) and examined using a microscope 
(Eclipse 80; Nikon). Appropriate rabbit control serum (Dako) and isotype 
controls (BD) were included. 180 ONTOGENY OF HUMAN HLA-DR  +   SKIN LEUKOCYTES   | Schuster et al. 
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